US-Listed Pharmaceutical Preparations — Operating Income Percentiles, FY 2025

Population: 469 US-listed companies (SIC 2834), fiscal year 2025; fiscal year ends 2025-06-30 to 2026-05-31.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile	$-213.4M
25th percentile	$-98.1M
Median	$-28.0M
75th percentile	$-7.8M
90th percentile	$23.5M
Mean	$1.7M
Minimum	$-2.9B
Maximum	$15.1B

Methodology & sources
Operating Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2025 = fiscal years ending 2025-06-01 to 2026-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest Operating Income percentiles (live) · All Pharmaceutical Preparations benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2834/operating-income/2025